ENDRA Life Sciences Files Proxy Statement for August Meeting

TL;DR

ENDRA Life Sciences filed its proxy statement for the Aug 6th shareholder meeting. Vote your shares!

AI Summary

ENDRA Life Sciences Inc. filed its definitive proxy statement (DEF 14A) on June 25, 2024, for its annual meeting on August 6, 2024. The filing concerns the solicitation of proxies from shareholders regarding matters to be voted on at the meeting. The company is incorporated in Delaware and headquartered in Ann Arbor, Michigan.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda and proposals for the upcoming annual meeting, allowing them to make informed voting decisions on company governance and strategic direction.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing, which is standard for public companies to solicit shareholder votes.

Key Numbers

• 20240806 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
• 20240625 — Filing Date (Date the proxy statement was submitted to the SEC.)

Key Players & Entities

• ENDRA Life Sciences Inc. (company) — Registrant
• 0001654954-24-008176 (filing_id) — Accession Number
• 20240625 (date) — Filing Date
• 20240806 (date) — Meeting Date
• Ann Arbor, Michigan (location) — Company Headquarters

FAQ

Key Financial Figures

• $1,000 — ecord date based upon an issue price of $1,000 per share, subject to adjustment for ac
• $17.40 — ed dividends, and a conversion price of $17.40 per share. Accordingly, as of the recor

Filing Documents

• ndra_def14a.htm (DEF 14A) — 540KB
• ndra_pre14aimg10.jpg (GRAPHIC) — 3KB
• ndra_pre14aimg11.jpg (GRAPHIC) — 7KB
• ndra_pre14aimg12.jpg (GRAPHIC) — 33KB
• ndra_pre14aimg15.jpg (GRAPHIC) — 159KB
• ndra_pre14aimg16.jpg (GRAPHIC) — 132KB
• ndra_pre14aimg7.jpg (GRAPHIC) — 7KB
• ndra_pre14aimg8.jpg (GRAPHIC) — 2KB
• ndra_pre14aimg9.jpg (GRAPHIC) — 7KB
• 0001654954-24-008176.txt ( ) — 1025KB

From the Filing

DEF 14A 1 ndra_def14a.htm DEF 14A ndra_pre14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to Rule 14a-12 ENDRA LIFE SCIENCES INC. (Name of Registrant as Specified in its Charter) ___________________________________________________ (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee previously paid with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. 3600 Green Court, Suite 350 Ann Arbor, Michigan 48105 June 25, 2024 Dear Stockholder: You are cordially invited to attend the annual meeting of stockholders of ENDRA Life Sciences Inc. to be held at 10:00 a.m., Eastern Time, on August 6, 2024. This year's annual meeting will be completely virtual and conducted via live webcast. You may attend the annual meeting on the internet at www.virtualshareholdermeeting.com/NDRA2024. Prior to the meeting you may submit questions by logging into proxyvote.com and, prior to and during the meeting until polls are closed, you may vote by logging into www.virtualshareholdermeeting.com/NDRA2024 using your shareholder information provided on the Notice of Internet Availability of Proxy Materials described below. We are using the "Notice and Access" method of providing proxy materials to you via the internet. We believe that this process should provide you with a convenient and quick way to access your proxy materials and vote your shares, while allowing us to conserve natural resources and reduce the costs of printing and distributing the proxy materials. On or about June 25, 2024, we are mailing to our stockholders a Notice of Internet Availability of Proxy Materials (the "Notice") containing instructions on how to access our proxy statement and vote electronically via the internet or by telephone. The Notice also contains instructions on how to receive a paper copy of your proxy materials. We look forward to your participation in the annual meeting by attending virtually or by submitting your proxy. Further details regarding the matters to be acted upon at this meeting appear in the accompanying Notice and Proxy Statement. Please give this material your careful attention. Very truly yours, Irina Pestrikova Senior Director of Finance and Secretary ENDRA Life Sciences Inc. 3600 Green Court, Suite 350 Ann Arbor, Michigan 48105 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held on August 6, 2024 To the Stockholders of ENDRA Life Sciences Inc.: NOTICE IS HEREBY GIVEN that the 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting") of ENDRA Life Sciences Inc., a Delaware corporation, will take place on August 6, 2024 at 10:00 a.m., Eastern Time. The annual meeting will be a virtual meeting, held on the internet at www.virtualshareholdermeeting.com/NDRA2024, for the following purposes: 1. To elect the five nominees to the Board of Directors nominated by the Board of Directors. 2. To hold an advisory vote on executive compensation. 3. To hold a vote to authorize the issuance of shares of Common Stock upon the exercise of certain warrants sold in our recent public offering, and approve certain adjustment provisions included in such warrants. 4. To hold a vote on the approval of an amendment to our Certificate of Incorporation increasing the number of authorized shares of Common Stock from 80,000,000 shares to 1,000,000,000 shares. 5. To hold a vote on the approval of an amendment to our Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of our Common Stock at a stock split ratio between 1-for-20 and 1-for-50, inclusive, with the ultimate ratio to be determined by the Board of Directors in its sole discretion. 6. To ratify the appointment of RBSM LLP as our independent registered public accounting firm for 2024. 7. To transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof. To ensure that each stockholder's vote is counted at the 2024 Annual Meeting, stockholders are requested to complete, sign, date and return the proxy cards provided to them as promptly as possible in the envelope provided, or to submit their proxies by Internet, as described in the proxy cards mailed to them. Stockholders may also submit their voting instructions by telephone as described

View Full Filing

View this DEF 14A filing on SEC EDGAR